Literature DB >> 11504126

Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease: report of three cases.

S Kuroda1, K Houkin, H Kamiyama, H Abe.   

Abstract

OBJECTIVE AND IMPORTANCE: The beneficial effects of surgical revascularization on rebleeding in moyamoya disease remain unclear. This report is intended to clarify the effects of surgical revascularization on peripheral artery aneurysms, which represent one of the causes of intracranial bleeding in moyamoya disease. CLINICAL
PRESENTATION: Findings for three female patients who experienced intracranial bleeding are presented. Cerebral angiography revealed that intracranial bleeding resulted from the rupture of peripheral artery aneurysms arising from dilated collateral vessels such as the lenticulostriate artery. INTERVENTION: The patients successfully underwent superficial temporal artery-middle cerebral artery anastomosis combined with encephaloduromyoarteriosynangiosis. Angiography demonstrated obliteration of the peripheral artery aneurysms, together with the disappearance or decrease in caliber of the parent collateral arteries, after surgery. None of the patients experienced rebleeding during the follow-up period (up to 52 mo).
CONCLUSION: The results strongly suggest that surgical revascularization potentially improves cerebral circulation and decreases hemodynamic stress on collateral vessels, obliterating peripheral artery aneurysms.

Entities:  

Mesh:

Year:  2001        PMID: 11504126     DOI: 10.1097/00006123-200108000-00039

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  22 in total

1.  Location-based treatment of intracranial aneurysms in moyamoya disease: a systematic review and descriptive analysis.

Authors:  Anthony S Larson; Lorenzo Rinaldo; Waleed Brinjikji; Giuseppe Lanzino
Journal:  Neurosurg Rev       Date:  2020-05-08       Impact factor: 3.042

2.  Deep Intracerebral Hemorrhage Caused by Rupture of Distal Lenticulostriate Artery Aneurysm : A Report of Two Cases and a Literature Review.

Authors:  Yeon Soo Choo; Yong Bae Kim; Yong Sam Shin; Jin Yang Joo
Journal:  J Korean Neurosurg Soc       Date:  2015-11-30

3.  Ventricular Microaneurysms in Moyamoya Angiopathy Visualized with 7T MR Angiography.

Authors:  T Matsushige; M Kraemer; M Schlamann; P Berlit; M Forsting; M E Ladd; U Sure; K H Wrede
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-05       Impact factor: 3.825

4.  "Brush Sign" on susceptibility-weighted MR imaging indicates the severity of moyamoya disease.

Authors:  N Horie; M Morikawa; A Nozaki; K Hayashi; K Suyama; I Nagata
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

Review 5.  Moyamoya disease in children.

Authors:  David M Ibrahimi; Rafael J Tamargo; Edward S Ahn
Journal:  Childs Nerv Syst       Date:  2010-07-04       Impact factor: 1.475

Review 6.  "Sit back, observe, and wait." Or is there a pharmacologic preventive treatment for cerebral aneurysms?

Authors:  Marcelo M Valença
Journal:  Neurosurg Rev       Date:  2012-10-16       Impact factor: 3.042

7.  A rare case of a ruptured middle meningeal aneurysm causing intracerebral hematoma in a patient with moyamoya disease.

Authors:  Christopher J Koebbe; Michael B Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

8.  Lenticulostriate artery aneurysm presenting as primary intraventricular haemorrhage.

Authors:  Trilochan Srivastava; Raghavendra Bakki Sannegowda; Bhawna Sharma; Shankar Tejwani
Journal:  BMJ Case Rep       Date:  2013-06-26

9.  Embolization of an unruptured distal lenticulostriate aneurysm associated with moyamoya disease.

Authors:  J H Harreld; A R Zomorodi
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

10.  Cerebral Aneurysms with Internal Carotid Artery Agenesis: A Unique Case Similar to Moyamoya Disease and Literature Review.

Authors:  Soichiro Takamiya; Tetsuyuki Yoshimoto; Katsuhiko Maruichi
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-04-15       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.